Skip to main content
. 2019 Mar 7;2019:9496419. doi: 10.1155/2019/9496419

Figure 8.

Figure 8

A nicotinic agonist enhances the survival rate in the murine model of CVB3-induced myocarditis via α3β4-nAChR/PI3K/Akt-dependent survivin upregulation. (a) Kaplan-Meier survival analysis of viral myocarditis mice in the study. Survival proportions at day 7 were 100% for the normal control group, 42.9% for the CVB3-infected group, 70.7% for the nicotine-treated group, 27.6% for the α-CTX AuIB-treated group, and 31.0% for the LY294002-treated group. (b) The expression of pAkt, survivin, and Cleaved Caspase-3 was measured by western blot. aP < 0.05 vs. the CVB3-infected group. bP < 0.05 vs. the nicotine-treated group.